A team of researchers say they better understand why some people with COVID-19 also experience dizziness, ringing in the ears or other hearing issues. At the College of Medicine – Tucson, Shaowen Bao, PhD, an assistant professor of physiology, is currently working on a research survey of people who reported tinnitus after receiving the vaccine. He hopes to publish his findings in a scientific journal later this year.

The University of Arizona Health Sciences has been awarded a $2.1 million grant by the National Institutes of Health to fund a three-year study examining the link between normal knee aging and osteoarthritis. C. Kent Kwoh, MD, director of the UArizona Arthritis Center and chief of the Division of Rheumatology in the UArizona College of Medicine – Tucson, will lead the study.

The College of Nursing, Mel and Enid Zuckerman College of Public Health and R. Ken Coit College of Pharmacy posted significant gains in research funding.

Orthopedic surgeon Dr. Gens Goodman will give a free lecture to expand awareness about surgical and nonsurgical treatment options for osteoarthritis.

University of Arizona – Banner Health All of Us Program team leads the country as it closes in on 50,000 participants.

Aphasia – a difficulty in producing or understanding words and language, both written and spoken – often results following a stroke that damages parts of the brain that produce and decode language. "When patients who have experienced a left-brain stroke suddenly find out they can no longer speak, or speak only haltingly, it's a dramatic situation," said Steven Z. Rapcsak, MD, a professor of neurology in the College of Medicine – Tucson. "In many cases, they have the thoughts and know what they're trying to express, but they just don't have the words."

Statistics from a 2019 report by the UArizona Center for Rural Health are cited in an opinion column about the health care worker shortage in northern Arizona.

In a presentation at the annual American Academy of Asthma, Allergy and Immunology meeting, Tara Carr, MD, an associate professor in the College of Medicine – Tucson, presented results of a post hoc analysis that assessed the efficacy of tezepelumab in a broad population of patients with severe, uncontrolled asthma and common respiratory comorbidities.